Sysmex Deutschland
Menu

Early identification of haematologic malignancies using a complete blood count

Being diagnosed with haematologic malignancy actually happens either because the patient presents with certain symptoms or – as is becoming increasingly common – there are incidental findings during routine blood screening. This white paper describes how a complete blood count measured on Sysmex XN-Series analysers may reveal significant abnormalities and improve the incidental findings of haematologic malignancies or the relapse of cancer under treatment early on.
File type:
pdf
File size:
496 KB
Release:
08-03-22
Copyright © Sysmex Europe SE. All rights reserved.